MENU
PHAR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pharming Group (PHAR) Earnings Date & Reports

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need... Show more

A.I. Advisor
published Earnings

PHAR is expected to report earnings to fall 66.23% to 10 cents per share on March 18

Pharming Group PHAR Stock Earnings Reports
Q4'26
Est.
$0.10
Q3'26
Missed
by $0.03
Q2'26
Missed
by $0.04
Q1'26
Missed
by $0.08
Q4'25
Beat
by $0.02
The last earnings report on October 27 showed earnings per share of 30 cents, missing the estimate of 33 cents. With 8.20K shares outstanding, the current market capitalization sits at 869.86M.